The Lundquist Institute at Harbor-UCLA Medical Center

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE)	Skin and Connective Tissue Diseases, autoimmune disease, connective tissue disorder, cutaneous lupus erythematosus, discoid lupus erythematosus, immune system disorder, skin disorder, systemic lupus erythematosus	Active, not recruiting	Phase 2	2026-07-20		NCT05540327
Study to Evaluate the Safety and Efficacy of Adalimumab in MPS I, II, and VI	Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Mucopolysaccharidosis I, Neurobehavioral Manifestations, Neurologic Manifestations, Nutritional and Metabolic Diseases, Skin and Connective Tissue Diseases, X-linked disease, connective tissue disorder, cutaneous mucinosis, hereditary disease, inborn carbohydrate metabolic disorder, inborn errors of metabolism, inherited neurodegenerative disorder, intellectual disability, lysosomal storage disease, metabolic disease, mucopolysaccharidosis, mucopolysaccharidosis type 2, mucopolysaccharidosis type 6, nervous system disorder	Active, not recruiting	Phase 1 / Phase 2	2026-02-02		NCT03153319

Clinical trials